SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-056880
Filing Date
2023-05-08
Accepted
2023-05-08 08:14:45
Documents
13
Period of Report
2023-05-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314931d1_8k.htm   iXBRL 8-K 25598
2 EXHIBIT 99.1 tm2314931d1_ex99-1.htm EX-99.1 18606
  Complete submission text file 0001104659-23-056880.txt   225391

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eyen-20230508.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20230508_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20230508_pre.xml EX-101.PRE 22595
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2314931d1_8k_htm.xml XML 3698
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 23895934
SIC: 2834 Pharmaceutical Preparations